PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19184424-0	2010	Chronic aspirin use suppresses CDH1 methylation in human gastric mucosa.	Aspirin	8-15	cadherin 1	Homo sapiens	31-35	
19184424-4	2010	We investigated the methylation status of CDH1 in noncancerous gastric mucosa in chronic aspirin user, and assessed its effect on methylation-associated carcinogenesis.	Aspirin	89-96	cadherin 1	Homo sapiens	42-46	
19184424-8	2010	CDH1 methylation more frequently occurred in H. pylori-infection-positive subjects (P < 0.0001), while chronic aspirin users had a significantly lower risk of CDH1 methylation [nonuser versus user 36.1% versus 10.8%; odds ratio (OR) = 0.21, 95% confidence interval (CI) = 0.07-0.63, P = 0.005].	Aspirin	114-121	cadherin 1	Homo sapiens	162-166	
19184424-9	2010	Logistic regression analysis showed that chronic aspirin use was the independent factor for lower risk of CDH1 methylation (adjusted OR = 0.21, 95%CI = 0.07-0.66, P = 0.008).	Aspirin	49-56	cadherin 1	Homo sapiens	106-110	
19184424-10	2010	Chronic aspirin use was associated with lower risk of CDH1 methylation in H. pylori-positive subjects (nonuser versus user 49.5% versus 19.0%; OR = 0.24, 95%CI = 0.08-0.76, P = 0.01).	Aspirin	8-15	cadherin 1	Homo sapiens	54-58	
19184424-13	2010	Our data suggest that chronic aspirin use is associated with reduced risk of CDH1 methylation in human gastric mucosa.	Aspirin	30-37	cadherin 1	Homo sapiens	77-81